 | • レポートコード：GIR-105X05836 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、エダラボン注射のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。エダラボン注射の種類別市場規模（20ml、100ml）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・エダラボン注射の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Mitsubishi Tanabe Pharma ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：20ml、100ml ・用途別分析2016年-2026年：病院、薬局 ・エダラボン注射の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・エダラボン注射のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・エダラボン注射のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・エダラボン注射の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・エダラボン注射の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Edaravone Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Edaravone Injection size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Edaravone Injection market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Edaravone Injection market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
20ml
100ml
Market segment by Application can be divided into
Hospital
Pharmacy
The key market players for global Edaravone Injection market are listed below:
Mitsubishi Tanabe Pharma
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Edaravone Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Edaravone Injection Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 20ml
1.2.3 100ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Edaravone Injection Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Edaravone Injection Market Size & Forecast
1.4.1 Global Edaravone Injection Sales in Value (2016-2026))
1.4.2 Global Edaravone Injection Sales in Volume (2016-2026)
1.4.3 Global Edaravone Injection Price by Type (2016-2026) & (USD/MT)
1.5 Global Edaravone Injection Production Capacity Analysis
1.5.1 Global Edaravone Injection Total Production Capacity (2016-2026)
1.5.2 Global Edaravone Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Edaravone Injection Market Drivers
1.6.2 Edaravone Injection Market Restraints
1.6.3 Edaravone Injection Trends Analysis
2 Manufacturers Profiles
2.1 Mitsubishi Tanabe Pharma
2.1.1 Mitsubishi Tanabe Pharma Details
2.1.2 Mitsubishi Tanabe Pharma Major Business
2.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Product and Services
2.1.4 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Edaravone Injection Sales by Manufacturer
3.1 Global Edaravone Injection Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Edaravone Injection Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Edaravone Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Edaravone Injection Manufacturer Market Share
3.4.2 Top 6 Edaravone Injection Manufacturer Market Share
3.5 Global Edaravone Injection Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Edaravone Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Edaravone Injection Market Size by Region
4.1.1 Global Edaravone Injection Sales in Volume by Region (2016-2026)
4.1.2 Global Edaravone Injection Revenue by Region (2016-2026)
4.2 North America Edaravone Injection Revenue (2016-2026)
4.3 Europe Edaravone Injection Revenue (2016-2026)
4.4 Asia-Pacific Edaravone Injection Revenue (2016-2026)
4.5 South America Edaravone Injection Revenue (2016-2026)
4.6 Middle East and Africa Edaravone Injection Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Edaravone Injection Sales in Volume by Type (2016-2026)
5.2 Global Edaravone Injection Revenue by Type (2016-2026)
5.3 Global Edaravone Injection Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Edaravone Injection Sales in Volume by Application (2016-2026)
6.2 Global Edaravone Injection Revenue by Application (2016-2026)
6.3 Global Edaravone Injection Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Edaravone Injection Sales by Type (2016-2026)
7.2 North America Edaravone Injection Sales by Application (2016-2026)
7.3 North America Edaravone Injection Market Size by Country
7.3.1 North America Edaravone Injection Sales in Volume by Country (2016-2026)
7.3.2 North America Edaravone Injection Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Edaravone Injection Sales by Type (2016-2026)
8.2 Europe Edaravone Injection Sales by Application (2016-2026)
8.3 Europe Edaravone Injection Market Size by Country
8.3.1 Europe Edaravone Injection Sales in Volume by Country (2016-2026)
8.3.2 Europe Edaravone Injection Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Edaravone Injection Sales by Type (2016-2026)
9.2 Asia-Pacific Edaravone Injection Sales by Application (2016-2026)
9.3 Asia-Pacific Edaravone Injection Market Size by Region
9.3.1 Asia-Pacific Edaravone Injection Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Edaravone Injection Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Edaravone Injection Sales by Type (2016-2026)
10.2 South America Edaravone Injection Sales by Application (2016-2026)
10.3 South America Edaravone Injection Market Size by Country
10.3.1 South America Edaravone Injection Sales in Volume by Country (2016-2026)
10.3.2 South America Edaravone Injection Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Edaravone Injection Sales by Type (2016-2026)
11.2 Middle East & Africa Edaravone Injection Sales by Application (2016-2026)
11.3 Middle East & Africa Edaravone Injection Market Size by Country
11.3.1 Middle East & Africa Edaravone Injection Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Edaravone Injection Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Edaravone Injection Typical Distributors
12.3 Edaravone Injection Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Edaravone Injection Revenue by Type, (USD Million), 2021-2026
Table 2. Global Edaravone Injection Revenue by Application, (USD Million), 2021-2026
Table 3. Mitsubishi Tanabe Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Mitsubishi Tanabe Pharma Major Business
Table 5. Mitsubishi Tanabe Pharma Edaravone Injection Product and Services
Table 6. Mitsubishi Tanabe Pharma Edaravone Injection Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Edaravone Injection Sales by Manufacturer (2019-2021e) & (K MT)
Table 8. Global Edaravone Injection Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Edaravone Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Edaravone Injection Production Capacity by Company, (K MT): 2020 VS 2021
Table 11. Head Office and Edaravone Injection Production Site of Key Manufacturer
Table 12. Global Edaravone Injection Sales by Region (2016-2021e) & (K MT)
Table 13. Global Edaravone Injection Sales by Region (2021-2026) & (K MT)
Table 14. Global Edaravone Injection Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Edaravone Injection Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Edaravone Injection Sales by Type (2016-2021e) & (K MT)
Table 17. Global Edaravone Injection Sales by Type (2021-2026) & (K MT)
Table 18. Global Edaravone Injection Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Edaravone Injection Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Edaravone Injection Price by Type (2016-2021e) & (USD/MT)
Table 21. Global Edaravone Injection Price by Type (2021-2026) & (USD/MT)
Table 22. Global Edaravone Injection Sales by Application (2016-2021e) & (K MT)
Table 23. Global Edaravone Injection Sales by Application (2021-2026) & (K MT)
Table 24. Global Edaravone Injection Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Edaravone Injection Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Edaravone Injection Price by Application (2016-2021e) & (USD/MT)
Table 27. Global Edaravone Injection Price by Application (2021-2026) & (USD/MT)
Table 28. North America Edaravone Injection Sales by Country (2016-2021e) & (K MT)
Table 29. North America Edaravone Injection Sales by Country (2021-2026) & (K MT)
Table 30. North America Edaravone Injection Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Edaravone Injection Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Edaravone Injection Sales by Type (2016-2021e) & (K MT)
Table 33. North America Edaravone Injection Sales by Type (2021-2026) & (K MT)
Table 34. North America Edaravone Injection Sales by Application (2016-2021e) & (K MT)
Table 35. North America Edaravone Injection Sales by Application (2021-2026) & (K MT)
Table 36. Europe Edaravone Injection Sales by Country (2016-2021e) & (K MT)
Table 37. Europe Edaravone Injection Sales by Country (2021-2026) & (K MT)
Table 38. Europe Edaravone Injection Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Edaravone Injection Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Edaravone Injection Sales by Type (2016-2021e) & (K MT)
Table 41. Europe Edaravone Injection Sales by Type (2021-2026) & (K MT)
Table 42. Europe Edaravone Injection Sales by Application (2016-2021e) & (K MT)
Table 43. Europe Edaravone Injection Sales by Application (2021-2026) & (K MT)
Table 44. Asia-Pacific Edaravone Injection Sales by Region (2016-2021e) & (K MT)
Table 45. Asia-Pacific Edaravone Injection Sales by Region (2021-2026) & (K MT)
Table 46. Asia-Pacific Edaravone Injection Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Edaravone Injection Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Edaravone Injection Sales by Type (2016-2021e) & (K MT)
Table 49. Asia-Pacific Edaravone Injection Sales by Type (2021-2026) & (K MT)
Table 50. Asia-Pacific Edaravone Injection Sales by Application (2016-2021e) & (K MT)
Table 51. Asia-Pacific Edaravone Injection Sales by Application (2021-2026) & (K MT)
Table 52. South America Edaravone Injection Sales by Country (2016-2021e) & (K MT)
Table 53. South America Edaravone Injection Sales by Country (2021-2026) & (K MT)
Table 54. South America Edaravone Injection Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Edaravone Injection Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Edaravone Injection Sales by Type (2016-2021e) & (K MT)
Table 57. South America Edaravone Injection Sales by Type (2021-2026) & (K MT)
Table 58. South America Edaravone Injection Sales by Application (2016-2021e) & (K MT)
Table 59. South America Edaravone Injection Sales by Application (2021-2026) & (K MT)
Table 60. Middle East & Africa Edaravone Injection Sales by Country (2016-2021e) & (K MT)
Table 61. Middle East & Africa Edaravone Injection Sales by Country (2021-2026) & (K MT)
Table 62. Middle East & Africa Edaravone Injection Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Edaravone Injection Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Edaravone Injection Sales by Type (2016-2021e) & (K MT)
Table 65. Middle East & Africa Edaravone Injection Sales by Type (2021-2026) & (K MT)
Table 66. Middle East & Africa Edaravone Injection Sales by Application (2016-2021e) & (K MT)
Table 67. Middle East & Africa Edaravone Injection Sales by Application (2021-2026) & (K MT)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Edaravone Injection Typical Distributors
Table 71. Edaravone Injection Typical Customers
List of Figures
Figure 1. Edaravone Injection Picture
Figure 2. Global Edaravone Injection Sales Market Share by Type in 2020
Figure 3. 20ml
Figure 4. 100ml
Figure 5. Global Edaravone Injection Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Edaravone Injection Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 9. Global Edaravone Injection Market Size and Forecast (2016-2026) & (USD Million)
Figure 10. United States Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 11. Canada Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Mexico Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Germany Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. France Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. United Kingdom Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Russia Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Italy Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. China Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Japan Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Korea Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. India Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Southeast Asia Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Australia Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Brazil Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Egypt Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Saudi Arabia Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. South Africa Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Turkey Edaravone Injection Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Global Edaravone Injection Sales (2016-2026) & (K MT)
Figure 30. Global Edaravone Injection Production Capacity (2016-2026) & (K MT)
Figure 31. Global Edaravone Injection Production Capacity by Geographic Region: 2020 VS 2021
Figure 32. Edaravone Injection Market Drivers
Figure 33. Edaravone Injection Market Restraints
Figure 34. Edaravone Injection Market Trends
Figure 35. Global Edaravone Injection Sales Market Share by Manufacturer in 2020
Figure 36. Global Edaravone Injection Revenue Market Share by Manufacturer in 2020
Figure 37. Edaravone Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 38. Top 3 Edaravone Injection Manufacturer (Revenue) Market Share in 2020
Figure 39. Top 6 Edaravone Injection Manufacturer (Revenue) Market Share in 2020
Figure 40. Global Edaravone Injection Sales Market Share by Region (2016-2026)
Figure 41. Global Edaravone Injection Revenue Market Share by Region (2016-2026)
Figure 42. North America Edaravone Injection Revenue (2016-2026) & (USD Million)
Figure 43. Europe Edaravone Injection Revenue (2016-2026) & (USD Million)
Figure 44. Asia-Pacific Edaravone Injection Revenue (2016-2026) & (USD Million)
Figure 45. South America Edaravone Injection Revenue (2016-2026) & (USD Million)
Figure 46. Middle East & Africa Edaravone Injection Revenue (2016-2026) & (USD Million)
Figure 47. Global Edaravone Injection Sales Market Share by Type (2016-2026)
Figure 48. Global Edaravone Injection Revenue Market Share by Type (2016-2026)
Figure 49. Global Edaravone Injection Price by Type (2016-2026) & (USD/MT)
Figure 50. Global Edaravone Injection Sales Market Share by Application (2016-2026)
Figure 51. Global Edaravone Injection Revenue Market Share by Application (2016-2026)
Figure 52. Global Edaravone Injection Price by Application (2016-2026) & (USD/MT)
Figure 53. North America Edaravone Injection Sales Market Share by Country (2016-2026)
Figure 54. North America Edaravone Injection Revenue Market Share by Country (2016-2026)
Figure 55. North America Edaravone Injection Sales Market Share by Type (2016-2026)
Figure 56. North America Edaravone Injection Sales Market Share by Application (2016-2026)
Figure 57. Europe Edaravone Injection Sales Market Share by Country (2016-2026)
Figure 58. Europe Edaravone Injection Revenue Market Share by Country (2016-2026)
Figure 59. Europe Edaravone Injection Sales Market Share by Type (2016-2026)
Figure 60. Europe Edaravone Injection Sales Market Share by Application (2016-2026)
Figure 61. Asia-Pacific Edaravone Injection Sales Market Share by Region (2016-2026)
Figure 62. Asia-Pacific Edaravone Injection Revenue Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Edaravone Injection Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Edaravone Injection Sales Market Share by Application (2016-2026)
Figure 65. South America Edaravone Injection Sales Market Share by Country (2016-2026)
Figure 66. South America Edaravone Injection Revenue Market Share by Country (2016-2026)
Figure 67. South America Edaravone Injection Sales Market Share by Type (2016-2026)
Figure 68. South America Edaravone Injection Sales Market Share by Application (2016-2026)
Figure 69. Middle East & Africa Edaravone Injection Sales Market Share by Country (2016-2026)
Figure 70. Middle East & Africa Edaravone Injection Revenue Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Edaravone Injection Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Edaravone Injection Sales Market Share by Application (2016-2026)
Figure 73. Sales Channel: Direct Channel vs Indirect Channel
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のマンニトール注射市場 2021：企業別、地域別、種類・用途別 The Mannitol Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…- 髄腔内バッファー電解質/デキストロース注入の世界市場2018-2025 buffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.In 2018, the global Buffered Intrathecal Electrolyte/Dextrose Injection…
- 髄腔内バッファー電解質/デキストロース注入薬の世界市場2018-2025 buffered intrathecal electrolyte/dextrose injection is indicated as a diluent for the intrathecal administration of methotrexate sodium and cytarabine for the prevention or treatment of meningeal leukemia or lymphocytic lymphoma.In 2018, the global Buffered Intrathecal Electrolyte/Dextrose Injection…
- 世界の注射用オマリズマブ市場 2021：企業別、地域別、種類・用途別 The Omalizumab for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…
- 硫酸ビンクリスチンリポソーム注射の世界市場2018-2025 Marqibo (vinCRIStine sulfate LIPOSOME injection) is vincristine encapsulated in sphingomyelin/cholesterol liposomes for intravenous administration.In 2018, the global Vincristine Sulfate Liposome Injection market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of …